Last updated: 11/07/2018 09:28:23
A meta-analysis of dose-exposure relationships for gabapentin following the administration of HORIZANT® or NEURONTIN®
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: A meta-analysis of dose-exposure relationships for gabapentin following the administration of HORIZANT® or NEURONTIN®
Trial description: A pharmacokinetic meta-analysis of gabapentin systemic exposure at a range of doses using data identified in public domain.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
pharmacokinetic exposure
Timeframe: single dose to 52 weeks
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
0
Primary completion date:
Not applicable
Observational study model:
Other
Time perspective:
Other
Clinical publications:
Chao Chen. Copy of GEN-1MS-00022684 Meta-analyses of dose-exposure relationshipts for gabapentin following oral administration of gabapentin and gabapentin enacarbil. Eur J Clin Pharmacol. 2013;69(10)
Medical condition
Neuralgia, Postherpetic
Product
gabapentin enacarbil
Collaborators
Not applicable
Study date(s)
October 2010 to November 2011
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female & Male
Age
Not applicable
Accepts healthy volunteers
yes
- N/A
Inclusion and exclusion criteria
Inclusion criteria:
- N/A -
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2011-25-11
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website